首页> 外文期刊>International Journal of Pharmaceutics >Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release.
【24h】

Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release.

机译:布比卡因负载的可生物降解的聚乳酸-乙醇酸微球I.药物掺入聚合物基质的优化和药物释放模型。

获取原文
获取原文并翻译 | 示例
           

摘要

Bupivacaine has been encapsulated by solvent evaporation method based on O/W emulsion, using poly(dl-lactic-co-glycolic) acid (PLGA) 50:50. The particle size can be controlled by changing stirring rate and polymer concentration. The encapsulation efficiency was affected by polymer concentration and burst effect of bupivacaine released from particles was affected by drug/polymer mass ratio. Orthogonal design was used to optimize the formulation according to drug content, encapsulation efficiency and burst effect. The dissolution profile and release model were evaluated with two different bupivacaine microspheres (bupi-MS) groups including low drug loading (6.41%) and high drug loading (28.92%). It was observed that drug release was affected by drug loading especially the amount of drug crystal attached on surface of bupi-MS. The drug release profile of low drug loaded bupi-MS agreed with Higuchi equation and that of high drug loaded bupi-MS agreed with first order equation.
机译:布比卡因已通过基于O / W乳液的溶剂蒸发法,使用聚(dl-乳酸-共-乙醇酸)酸(PLGA)50:50进行封装。可以通过改变搅拌速率和聚合物浓度来控制粒度。包封效率受聚合物浓度的影响,布比卡因从颗粒中释放的破裂效果受药物/聚合物质量比的影响。正交设计用于根据药物含量,包封效率和爆破效果优化配方。用两个不同的布比卡因微球(bupi-MS)组评估了溶出度和释放模型,包括低载药量(6.41%)和高载药量(28.92%)。观察到药物释放受药物负载的影响,尤其是bupi-MS表面附着的药物晶体的数量。低载药bubu-MS的药物释放曲线与Higuchi方程一致,高载药bupi-MS的药物释放曲线与一阶方程一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号